Latest AI and machine learning research in schizophrenia for healthcare professionals.
Vision-language models (VLMs) represent an emerging class of multimodal artificial intelligence (AI) systems that integrate visual information with natural-language understanding and generation. In computational pathology, VLMs provide a framework for aligning histologic morphology from whole slide images (WSIs) with pathology reports, and other text-based knowledge sources. This review summarizes...
Affective and non-affective psychoses exhibit heterogeneous clinical presentation, neurobiological underpinnings, and treatment response. This special issue integrates multimodal findings to examine overlapping and distinct neural substrates in the psychosis spectrum. In this context, longitudinal designs appear essential to observe the developmental trajectory of patients and advance real-world p...
OBJECTIVE: Data extraction is among the most resource-intensive and error-prone stages of systematic review production. Large language models (LLMs) o...
Artificial intelligence (AI), particularly foundation and generative models, is reshaping the practice of hepatology through enhanced knowledge synthe...
Psychosis prevention relies on early detection of individuals at clinical high risk for psychosis (CHR-P). The effectiveness of the CHR-P state is con...
BACKGROUND: Schizophrenia (SZ) patients exhibit abnormalities in language expression, including semantic confusion and apathy, which significantly imp...
BACKGROUND: Patients undergoing invasive procedures frequently experience anxiety and often have unanswered questions regarding the procedure. Althoug...
Neuronal functional diversity and pathological vulnerability are governed by multi-layered regulatory programs. While high-throughput omics and neuroi...
Misuse of statistical methods in biomedical research remains widespread, undermining scientific integrity and public health. Flawed analyses can lead ...
We propose TB-GCAN, a tri-branch cross-attention graph neural network for schizophrenia classification using multimodal MRI, including sMRI, fMRI, and...
Generative artificial intelligence has shown great promise in structure-based drug design (SBDD), yet existing models often suffer from a fundamental ...
BACKGROUND: Psychiatric disorders represent a major burden for patients with epilepsy (PwE). This study examined how demographic, epilepsy-related, an...
Designer receptors exclusively activated by designer drugs (DREADDs) enable reversible control of specific neural circuits, but the pharmacological ne...
Social-affective changes are early indicators of psychosis relapse, yet their dynamic and subjective nature makes them difficult to capture between ro...
BACKGROUND: Standard echocardiography reports use complex terminology, limiting patient comprehension and exacerbating preconsultation anxiety. Large ...
INTRODUCTION: Large language models (LLMs) are being studied as oncology decision-support tools but can produce inaccurate outputs. We compared LLM pe...
BACKGROUND: The evaluation and improvement of medical large language models (LLMs) are critical for their real-world deployment, particularly in ensur...
OBJECTIVE: Most hallucination mitigation for large language models (LLMs) operates post-hoc, leaving safety-critical clinical deployment without real-...
Psychiatric, neurodevelopmental, and neurodegenerative disorders, including Alzheimer's disease (AD), attention-deficit/hyperactivity disorder (ADHD),...
BACKGROUND: Dementia affects over 55Â million people worldwide. Mild cognitive impairment (MCI) often precedes Alzheimer's disease (AD). Clinical manag...